Search
forResearch 10 of 502
- Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Caractérisation des Réactions Paradoxales Psoriasiformes Alopéciantes Induites par les Anti-TNFα chez des Patients Atteints de Maladies Inflammatoires Chroniques de l’Intestin
- 1113 Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via Ly6 antigen for psoriasiform dermatitis alleviation
- 713 Fisetin promotes differentiation, inhibits proliferative and inflammatory responses in cultured human cells and alleviates psoriasiform dermatitis in mice
- ZNF750 safeguards upper hair follicle homeostasis to prevent inflammatory skin disease
- Loss of epidermal Evi/Wls results in a phenotype resembling psoriasiform dermatitis
- Tumor necrosis factor-alpha inhibitor associated psoriasiform alopecia (drug-induced psoriasiform alopecia)
- 176 Myeloid cell-specific deletion of mTOR suppresses psoriasis-like skin inflammation in C57BL/6 mice
- 305 Overlaps between inflammatory dermatoses and ichthyoses: need for novel therapeutic approaches
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →